TABLE 1.
Compounds extracted from Momordica charantia L. and their health benefits.
| Compound | Structure | Health benefits | References |
|---|---|---|---|
| Momordicoside F2 |
|
Anti-inflammatory and anti-cancer | Ju et al. (2004), Cao et al. (2018) |
| Goyaglycoside B |
|
Anti-cancer | Raina et al. (2016), Cao et al. (2018) |
| Karaviloside III |
|
Anti-aging | Cao et al. (2018) |
| Charantoside VI |
|
Anti-aging | Cao et al. (2018) |
| Charantagenin E |
|
Anti-aging | Cao et al. (2018) |
| Charantoside II |
|
Anti-aging | Cao et al. (2018) |
| Momordicoside G |
|
Anti-aging | Cao et al. (2018) |
| Goyaglycoside D |
|
Anti-cancer | Wang et al. (2012), Cao et al. (2018) |
| Stigmasterol glucoside |
|
Anti-angiogenic and anti-cancer | Desai and Tatke, (2015), Kangsamaksin et al. (2017) |
| β-sitosterol glucoside |
|
Cholesterol reduction and immune system modulation | Kaur et al. (2011), Desai and Tatke, (2015) |
| (19R)-7β,19-epoxy-19-methoxycucurbita-5,24-dien-3β,23-diol |
|
Anti-aging | Jiang et al. (2016), Cao et al. (2018) |
| Kuguacin J |
|
Anti-cancer | Limtrakul et al. (2013), Chen et al. (2015) |
| Cucurbitane triterpenoid |
|
Prevention and therapy of human breast cancer | Liu et al. (2009), Bishayee et al. (2011) |
| Cucurbitane triterpenoid |
|
Anti-cancer | Liu et al. (2009), Bishayee et al. (2011) |
| Steroidal glycoside |
|
Reduce blood sugar level | Liu et al. (2009), Tan et al. (2015b), Lee et al. (2021) |